New Stock News | Zhengxiang Pharmaceutical Submits Application to Hong Kong Stock Exchange Again
According to a disclosure by the Hong Kong Stock Exchange on August 26, Zhengxiang Pharmaceutical (Nanjing) Group Co., Ltd. has submitted a listing application to the main board of the Hong Kong Stock Exchange, with CICC acting as the sole sponsor.
According to the Hong Kong Stock Exchange's disclosure on August 26, Zhengxiang Pharmaceutical (Nanjing) Group Co., Ltd. (referred to as: Zhengxiang Pharmaceutical) has submitted its listing application to the main board of the Hong Kong Stock Exchange, with CICC as the sole sponsor. The company previously submitted a listing application to the Hong Kong Stock Exchange on January 30, 2026.
The prospectus shows that Zhengxiang Pharmaceutical is a commercial-stage biopharmaceutical company dedicated to the research and commercialization of innovative therapies to meet the medical needs in the fields of viral infectious diseases, oncology, and inflammatory diseases, where existing treatment options are limited. The companys core product, Marzylorase Tablets, is an inhibitor targeting the polymerase acidic protein ("PA") endonuclease of the influenza virus, which received approval from the National Medical Products Administration ("NMPA") for a New Drug Application ("NDA") for the treatment of adult influenza in July 2025, and subsequently in June 2026 received approval for the treatment of adolescent patients; the company is also developing influenza prevention solutions for populations exposed to the virus.
Related Articles
HK Stock Market Move | Sinotrans Limited (00598) rose over 6% in the afternoon, with a year-on-year increase of 17.33% in mid-term net profit excluding non-recurring items. The agency business benefits from the high prosperity of international logistics.
HK Stock Market Move | SHINEWAY PHARM (02877) soared 12% in the afternoon, with first-half performance down more than 20%. It plans to distribute a second interim dividend of 80 cents.
HK Stock Market Move | WASION HOLDINGS (03393) saw a plunge of over 15% in the afternoon, with a year-on-year increase of only 1.41% in net profit for the first half of the year, and an overall gross profit margin falling to 31.28%.
HK Stock Market Move | Sinotrans Limited (00598) rose over 6% in the afternoon, with a year-on-year increase of 17.33% in mid-term net profit excluding non-recurring items. The agency business benefits from the high prosperity of international logistics.
HK Stock Market Move | SHINEWAY PHARM (02877) soared 12% in the afternoon, with first-half performance down more than 20%. It plans to distribute a second interim dividend of 80 cents.
HK Stock Market Move | WASION HOLDINGS (03393) saw a plunge of over 15% in the afternoon, with a year-on-year increase of only 1.41% in net profit for the first half of the year, and an overall gross profit margin falling to 31.28%.
RECOMMEND
